Skip to content

Registry for Chronic Obstructive Pulmonary Disease With Anxiety and Depression in China

The Early Detection, Clinical Course and Prognosis of Anxiety and Depression in Chronic Obstructive Pulmonary Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03187236
Enrollment
1906
Registered
2017-06-14
Start date
2017-06-15
Completion date
2020-12-31
Last updated
2017-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, COPD, Depression

Brief summary

Anxiety and depression are common comorbidities of chronic obstructive pulmonary disease (COPD). However, the exact prevalence is not known in China. COPD patients with anxiety and depression tend to have more severe symptoms and worse prognosis, but the related evidences are not strong enough. The study aim to investigate the prevalence and long-term outcome of anxiety and depression in COPD.

Interventions

None listed

Sponsors

Chinese Academy of Medical Sciences, Fuwai Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 80 Years

Inclusion criteria

* Stable chronic obstructive pulmonary disease (COPD) patients

Exclusion criteria

* Patients with bronchial asthma or other severe pulmonary diseases or having received pulmonary surgery in 6 months * Patients with tumor history during past 5 years * Patients with COPD exacerbations during past 4 weeks * Participants in clinical trials * Patients in pregnancy or breastfeeding * Patients unable to complete questionaire independently * Patients older than 80 years old * Patients receiving long-term domiciliary oxygen therapy

Design outcomes

Primary

MeasureTime frameDescription
moderate and severe COPD exacerbations3 yearstotal times

Secondary

MeasureTime frameDescription
All-cause mortality3 yearsmortality in %

Countries

China

Contacts

Primary ContactJiangna Han, MD
13520053104@139.com13520053104

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026